Rank: 20 (Previous rank: 38)
CEO: Robert Weiler
Headquarters: Waltham, MA
Revenue: $170.2 million
(four quarters to 12/31/08)
Return to investors: 8.69%
(three years to 12/81/08, annualized rate)
Phase Forward provides software that enables pharmaceutical, biotechnology, and medical device manufacturers to conduct clinical trials and drug safety tests more effectively. The World Economic Forum honored Phase Forward as a Technology Pioneer 2009, while the Dana-Farber/Harvard Cancer Center credited Phase Forward's software for helping reduce its data access times from eight weeks to real-time.
... What Readers Say
They speak out on the fastest-growing small public companies ...
|Executive||2008 Total Compensation